BioSpace News Archive

Oxiplex/IU® is CE marked and available in the European Union.

Data obtained in clinically relevant models, relative to the mechanism of action, key for the health claim submission file to regulatory authorities.

Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced that new results from the PERSEE study examining the use of Cellvizio during digestive surgery with live remote transmission to pathologist, which were published this month in Surgical Endoscopy, the official journal of SAGES (Society of American Gastrointestinal and Endoscopic Surgeons).

Nymox Pharmaceutical Corporation reported today that after long-term safety assessments of repeated Fexapotide Triflutate (FT) intraprostatic injections, there have been no identifiable risks or serious side effects or adverse events identified associated or linked with the drug.

Deaths from drug and alcohol misuse and suicide skyrocket, yet majority of states fail to provide mental health parity - prompting American families to take action against illegal insurance denials.

College enrollment and degrees awarded in STEM subjects are on the rise, and with more courses come more assignments that need to be graded. Turnitin has acquired Gradescope, an assessment platform that reduces the time associated with grading in college courses via an optimized online workflow and clever application of artificial intelligence.

Sage Therapeutics today announced that, on October 1, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 79,600 shares of its common stock to 11 new employees under Sage’s 2016 Inducement Equity Plan.

CPDC has appointed Dr. Joe McCann, CPDC’s current Chief Operating Officer, as its new CEO and President, effective immediately.

Research agreement for biofermentation development and scale-up processes for cannabinoid biosynthesis in E.coli.

Conference on Tuesday, October 9, 2018 at 8:30 a.m.